Title:
ＳＡＲＳ－ＣＯＶ－２阻害剤
Document Type and Number:
Japanese Patent JP2023542453
Kind Code:
A
Abstract:
配列番号：１～１７、１９～２１、２３～３４および１００～１０１から成る群から選択されるアミノ酸配列に対して少なくとも５０％、５５％、６０％、６５％、７０％、７５％、８０％、８５％、９０％、９１％、９２％、９３％、９４％、９５％、９６％、９７％、９８％、９９％、または１００％同一であるアミノ酸配列を含むＳＡＲＳ－ＣｏＶ－２のポリペプチド阻害剤、およびＳＡＲＳ－ＣｏＶ－２感染の発症を治療するおよび制限するためのそれらの用途を開示する。【選択図】なし
Inventors:
Khao, Ronshin
coventry, brian
Goreshnik, Inna
Miller, Lauren
BAKER,David
Kosodoi, Lisa
bowen, john
carter, lauren
case, james, brett
Diamond, michael
edman, natasha
hunt, andrew
Jewett, Michael, Christopher
Ogohara, Cassandra, Gene
Park, Yang Jun
Ravichandran, Rashmi
Stewart, Lance, Joseph
Wiesler, David
Vogeli, Bastian
Walls, Alexandra, Sea.
Wu, Kesia
boiken, scott
Ueda, George
coventry, brian
Goreshnik, Inna
Miller, Lauren
BAKER,David
Kosodoi, Lisa
bowen, john
carter, lauren
case, james, brett
Diamond, michael
edman, natasha
hunt, andrew
Jewett, Michael, Christopher
Ogohara, Cassandra, Gene
Park, Yang Jun
Ravichandran, Rashmi
Stewart, Lance, Joseph
Wiesler, David
Vogeli, Bastian
Walls, Alexandra, Sea.
Wu, Kesia
boiken, scott
Ueda, George
Application Number:
JP2023502638A
Publication Date:
October 10, 2023
Filing Date:
May 25, 2021
Export Citation:
Assignee:
University of Washington
NORTHWESTERN UNIVERSITY
NORTHWESTERN UNIVERSITY
International Classes:
C12N15/11; A61K31/7088; A61K35/12; A61K38/16; A61K39/395; A61K47/60; A61K47/61; A61K47/62; A61K47/69; A61K48/00; A61P31/14; C07K14/00; C07K16/00; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/13; C12N15/62; C12N15/63; C12Q1/6811; C12Q1/70
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Akiyo Iwahori
Rena Miyoshi
Kamoto Takahashi
Nao Oda
Akiyo Iwahori
Rena Miyoshi
Kamoto Takahashi